Perni, R. B., Almquist, S. J., Byrn, R. A., Chandorkar, G., Chaturvedi, P. R., Courtney, L. F., . . . Lin, C. (2006). Preclinical Profile of VX-950, a Potent, Selective, and Orally Bioavailable Inhibitor of Hepatitis C Virus NS3-4A Serine Protease. American Society for Microbiology.
Citação norma ChicagoPerni, Robert B., et al. Preclinical Profile of VX-950, a Potent, Selective, and Orally Bioavailable Inhibitor of Hepatitis C Virus NS3-4A Serine Protease. American Society for Microbiology, 2006.
Citação norma MLAPerni, Robert B., et al. Preclinical Profile of VX-950, a Potent, Selective, and Orally Bioavailable Inhibitor of Hepatitis C Virus NS3-4A Serine Protease. American Society for Microbiology, 2006.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.